Literature DB >> 19280766

Hepatic nuclear factor 1-alpha: inflammation, genetics, and atherosclerosis.

Angela D Armendariz1, Ronald M Krauss.   

Abstract

PURPOSE OF REVIEW: Increased plasma levels of C-reactive protein (CRP), a hepatic acute phase reactant, predict risk for coronary heart disease. There has been interest in identifying genetic determinants of CRP as a means of better understanding its regulation and its relation to coronary heart disease. We here review recent findings that have linked plasma CRP levels to single nucleotide polymorphisms in hepatic nuclear factor (HNF) 1-alpha, a transcription factor with a wide range of functions, including many involved in cholesterol, bile acid, and lipoprotein metabolism. RECENT
FINDINGS: Two genome-wide association studies have identified single nucleotide polymorphisms in several genes that are strongly related to plasma CRP levels, including several on chromosome 12 in the vicinity of the HNF1A gene. The CRP gene promoter has two HNF1-alpha-binding sites. Recently, it has been demonstrated that HNF1-alpha is required for cytokine-driven CRP expression and that this involves formation of a complex with STAT3 and c-Fos.
SUMMARY: Based on the recent genetic findings as well as delineation of the role of HNF1-alpha in regulating the expression of the CRP gene, it appears that this transcription factor may play a key role in linking metabolic and inflammatory pathways underlying the pathogenesis of coronary heart disease.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19280766     DOI: 10.1097/mol.0b013e3283295ee9

Source DB:  PubMed          Journal:  Curr Opin Lipidol        ISSN: 0957-9672            Impact factor:   4.776


  37 in total

1.  Promoter analysis of the human ascorbic acid transporters SVCT1 and 2: mechanisms of adaptive regulation in liver epithelial cells.

Authors:  Jack C Reidling; Stanley A Rubin
Journal:  J Nutr Biochem       Date:  2010-05-14       Impact factor: 6.048

Review 2.  Biology of proprotein convertase subtilisin kexin 9: beyond low-density lipoprotein cholesterol lowering.

Authors:  Giuseppe Danilo Norata; Hagai Tavori; Angela Pirillo; Sergio Fazio; Alberico L Catapano
Journal:  Cardiovasc Res       Date:  2016-08-05       Impact factor: 10.787

3.  [Biphasic (ulcer-forming and ulcer-preventing) effect of adrenaline in rats].

Authors:  T Dozaki; K Imai; S Mizukami
Journal:  Nihon Yakurigaku Zasshi       Date:  1975-07

4.  Identification of a FOXA-dependent enhancer of human alcohol dehydrogenase 4 (ADH4).

Authors:  Sirisha Pochareddy; Howard J Edenberg
Journal:  Gene       Date:  2010-04-02       Impact factor: 3.688

5.  Pleiotropic effects of HNF1A rs1183910 in a population-based study of 60,283 individuals.

Authors:  Kristine H Allin; Børge G Nordestgaard
Journal:  Diabetologia       Date:  2014-01-19       Impact factor: 10.122

6.  Expression profile of HMBOX1, a novel transcription factor, in human cancers using highly specific monoclonal antibodies.

Authors:  Jun Dai; Cai Zhang; Zhigang Tian; Jian Zhang
Journal:  Exp Ther Med       Date:  2011-03-21       Impact factor: 2.447

7.  Hepatic deletion of SIRT1 decreases hepatocyte nuclear factor 1α/farnesoid X receptor signaling and induces formation of cholesterol gallstones in mice.

Authors:  Aparna Purushotham; Qing Xu; Jing Lu; Julie F Foley; Xingjian Yan; Dong-Hyun Kim; Jongsook Kim Kemper; Xiaoling Li
Journal:  Mol Cell Biol       Date:  2012-01-30       Impact factor: 4.272

8.  Sex-specific gene expression in the BXD mouse liver.

Authors:  Daniel M Gatti; Ni Zhao; Elissa J Chesler; Blair U Bradford; Andrey A Shabalin; Roumyana Yordanova; Lu Lu; Ivan Rusyn
Journal:  Physiol Genomics       Date:  2010-06-15       Impact factor: 3.107

9.  Inhibition of PCSK9 transcription by berberine involves down-regulation of hepatic HNF1α protein expression through the ubiquitin-proteasome degradation pathway.

Authors:  Bin Dong; Hai Li; Amar Bahadur Singh; Aiqin Cao; Jingwen Liu
Journal:  J Biol Chem       Date:  2014-12-24       Impact factor: 5.157

10.  Regulators of gene expression as biomarkers for prostate cancer.

Authors:  Stacey S Willard; Shahriar Koochekpour
Journal:  Am J Cancer Res       Date:  2012-11-20       Impact factor: 6.166

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.